Eliem Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Eliem Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2022 to Q2 2024.
  • Eliem Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -46 %, a 31.5% decline year-over-year.
  • Eliem Therapeutics, Inc. annual Return On Assets for 2023 was -30.4 %, a 1.04% increase from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -46 -11 -31.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -13 +26.7 +67.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -30.4 +0.32 +1.04% Oct 1, 2023 Dec 31, 2023
Q3 2023 -32.3 -1.63 -5.32% Jul 1, 2023 Sep 30, 2023
Q2 2023 -35 -6.25 -21.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -39.7 -12.7 -47.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -30.8 Oct 1, 2022 Dec 31, 2022
Q3 2022 -30.7 Jul 1, 2022 Sep 30, 2022
Q2 2022 -28.7 Apr 1, 2022 Jun 30, 2022
Q1 2022 -26.9 Jan 1, 2022 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.